Folliculitis Treatment Cream

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Folliculitis Treatment Cream
Generic name: MICONAZOLE NITRATE
Manufacturer: TAGRID LLC
Product type: HUMAN OTC DRUG
SPL set ID: 32396be0-f74a-5483-e063-6294a90ab3ae
SPL ID: df9c4cbf-0be3-46db-9e66-40c6a2b5f0c1
Version: 2
Effective date: 2025-04-07
Source export date: 2026-10-12
Source partition: 4
Source file: https://download.open.fda.gov/drug/label/drug-label-0004-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-12/b939c18fdf51df171cf60ce5558819d08ac66bb16bb9991d48cbec91028d783e/drug-label-0004-of-0014.json.zip
Source manifest SHA-256: 7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
Import run: 20261013T011858Z
Imported at: 2026-10-13 01:39:25

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 13 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M005	openfda.application_number
brand name		Folliculitis Treatment Cream	openfda.brand_name
generic name		MICONAZOLE NITRATE	openfda.generic_name
manufacturer name		TAGRID LLC	openfda.manufacturer_name
ndc	package	85384-0004-1	openfda.package_ndc
ndc	package	85384-0004-2	openfda.package_ndc
ndc	product	85384-0004	openfda.product_ndc
ndc11	package	85384000401	derived:openfda.package_ndc
ndc11	package	85384000402	derived:openfda.package_ndc
rxcui		2712237	openfda.rxcui
spl id		df9c4cbf-0be3-46db-9e66-40c6a2b5f0c1	id
spl set id		32396be0-f74a-5483-e063-6294a90ab3ae	set_id
unii		VW4H1CYW1K	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

For external use only Do not use On children under 2 years of age unless directed by a doctor. Avoid contact with eyes. If contact occurs, rinse thoroughly with water. If swallowed,get medical help or contact a Poison Control Center right away. Stop use and ask a doctor if Irritation occurs. There is no improvement within 4 weeks. Discomfort persists. Store at 59-86°F (15-30°C). Close the cap tightly after use. support@tagridllc.com

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.